Understand the source comparison
Menopause Peptides: Research Application Comparison
Thymalin Thymic regeneration, immune modulation Inflammatory symptoms, joint pain, autoimmune flare 5–10mg subcutaneous 2–3×/week Bacteriostatic water, 2–8°C storage Best for women with concurrent autoimmune conditions or severe inflammatory joint symptoms dur
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- Thymic regeneration, immune modulation
- Inflammatory symptoms, joint pain, autoimmune flare
- 5–10mg subcutaneous 2–3×/week
- Bacteriostatic water, 2–8°C storage
- Best for women with concurrent autoimmune conditions or severe inflammatory joint symptoms during transition
- MK-677
- Ghrelin receptor agonist, GH secretagogue
- Bone density loss, lean mass decline, sleep fragmentation
- 12.5–25mg oral daily
- Oral compound, no reconstitution needed
- Gold standard for bone density preservation; requires glucose monitoring in insulin-resistant patients
- Cerebrolysin
- Neurotrophic factor complex, BDNF upregulation
- Cognitive fog, verbal recall impairment, processing speed
- 5–10mL IV or 1–2mL SC 3×/week
- Pre-formulated solution, refrigerate after opening
- Most evidence for cognitive symptoms; administration complexity limits home use
- Dihexa
- HGF receptor agonist, synaptogenesis
- Executive function decline, working memory deficits, vasomotor symptoms
- 5–10mg oral daily or 1–2mg subcutaneous
- Depends on formulation; lyophilized requires reconstitution
- Dual action on cognition and hypothalamic plasticity; limited long-term human data
- Cartalax
- Cartilage matrix synthesis, chondrocyte proliferation
- Joint degradation, mobility decline
- 10–20mg subcutaneous 2×/week
- Targets musculoskeletal symptoms secondary to estrogen loss; pairs well with Thymalin for inflammatory joint pain